Publications by authors named "C H van der Vaart"

Article Synopsis
  • Pelvic organ prolapse is a common issue in women, with pessary therapy being a popular non-surgical treatment, but many women (20-60%) stop using it within two years.
  • A study conducted in 22 Dutch hospitals aimed to identify patient characteristics that lead to discontinuation of pessary treatment over 24 months, analyzing various patient data.
  • Results showed that younger age and self-reported allergies were significant predictors of stopping pessary use, but many allergies were unspecified, indicating that more research is needed to fully understand these factors.*
View Article and Find Full Text PDF

Objective: To evaluate the cost-effectiveness of pessary therapy as an initial treatment option compared with surgery for moderate to severe pelvic organ prolapse (POP) symptoms in secondary care from a healthcare and a societal perspective.

Design: Economic evaluation alongside a multicentre randomised controlled non-inferiority trial with a 24-month follow-up.

Setting: 21 hospitals in the Netherlands, recruitment conducted between 2015 and 2022.

View Article and Find Full Text PDF

Introduction And Hypothesis: The puborectal muscle (PRM), one of the female pelvic floor (PF) muscles, can get damaged during vaginal delivery, leading to disorders such as pelvic organ prolapse. Current diagnosis involves ultrasound (US) imaging of the female PF muscles, but functional information is limited. Previously, we developed a method for strain imaging of the PRM from US images in order to obtain functional information.

View Article and Find Full Text PDF

Purpose: 4D Transperineal ultrasound (TPUS) is used to examine female pelvic floor disorders. Muscle movement, like performing a muscle contraction or a Valsalva maneuver, can be captured on TPUS. Our work investigates the possibility for unsupervised analysis and classification of the TPUS data.

View Article and Find Full Text PDF

Introduction And Hypothesis: New treatments are needed for pelvic floor disorders. ReGeneraTing Agent® (RGTA®) is a promising regenerative therapy. Therefore, the objective of this study was to compare regenerative abilities of mesenchymal stem cells (MSCs) and RGTA® on regeneration after simulated childbirth injury in rats.

View Article and Find Full Text PDF